FV2GP
Flagship Ventures 2007 General Partner Portfolio holdings
AUM
$107M
This Quarter Return
+59.38%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$228M
AUM Growth
+$228M
(+45%)
Cap. Flow
-$9.97M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Carisma Therapeutics
CARM
|
$31M |
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$25.2M |
| 2 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$15.8M |
Sector Composition
| 1 | Healthcare | 79.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Agios Pharmaceuticals
AGIO
$2.19B
| $151M | 66.31% |
3,860,738
| – | – |
|
|
RCPT
2
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $42.4M | 18.62% |
1,011,911
-600,000
| -37% | -$25.2M |
|
|
3
Carisma Therapeutics
CARM
$8.98M
| $31M | 13.58% |
+1,907,008
| New | +$31M |
|
|
BGMD
4
DELISTED
BG MEDICINE INC COM STK NEW
BGMD
| $3.39M | 1.49% |
1,764,286
| – | – |
|
|
TTPH
5
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| – | – |
-1,165,786
| Closed | -$15.8M |
|